Quantcast

Latest organ transplants Stories

2014-09-03 08:32:39

O'Hara lost two siblings to genetic heart failure when he faced dying of the same condition. The SynCardia Heart implant bridged him to a matching donor heart transplant. Today, Pat is doing great. TUCSON, Ariz., Sept. 3, 2014 /PRNewswire/ -- With the help of the SynCardia temporary Total Artificial Heart, Patrick "Pat" O'Hara was bridged to a donor heart transplant and beat genetic heart failure that claimed the lives of two siblings and caused a third to have a heart attack....

2014-08-26 08:29:21

The Tucson company manufactures the Total Artificial Heart, the world's only approved device that eliminates the source of end-stage biventricular failure, and the Freedom portable driver. TUCSON, Ariz., Aug. 26, 2014 /PRNewswire/ -- SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, is high on the Inc. 5000 named by the business magazine Inc. http://photos.prnewswire.com/prnvar/20140825/139411 "SynCardia manufactures the world's only FDA, Health Canada...

2014-08-20 16:24:51

HORSHOLM, Denmark, Aug. 20, 2014 /PRNewswire/ -- Highlights: -- On 28 July the European Commission granted marketing authorization for Envarsus® for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union (EU). -- Following the European marketing authorization Veloxis will receive a milestone payment of USD 15 million from our European partner Chiesi in the third quarter 2014 which is in line with...

2014-08-18 16:25:38

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Lung Transplantation-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278637/-Lung-Transplantation-Pipeline-Insights-2014.htmlSUMMARYDelveInsight's," Lung Transplantation-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that...

2014-08-11 23:04:13

Abington Health has achieved platinum-level recognition from the Hospital & Healthsystem Association of Pennsylvania (HAP) for its efforts to increase organ and tissue donor awareness and designations among employees, physicians, patients, visitors and the surrounding community. Abington, PA (PRWEB) August 11, 2014 Abington Health has achieved platinum-level recognition from the Hospital & Healthsystem Association of Pennsylvania (HAP) for its efforts to increase organ and tissue...

2014-08-06 16:30:24

Awards Ceremony To Celebrate High Donor Authorization Rate Among Latinos and Recognize Key Contributors CHICAGO, Aug. 6, 2014 /PRNewswire/ -- Gift of Hope Organ & Tissue Donor Network kicked off National Minority Donor Awareness week, (August 1-7), with the inaugural "Faces of Hope" Awards ceremony on July 31(st). The "Faces of Hope" distinction was awarded to Chicago city officials and professionals who through their work have delivered long-term benefits to Hispanics and to the...

2014-07-31 12:08:01

Dana-Farber Cancer Institute Study in NEJM reviews 10 years of data, argues for expansion of newborn screening Children born with so-called "bubble boy" disease have the best chance of survival if they undergo a hematopoietic stem cell transplant as soon after birth as possible, according to a detailed analysis of 10 years of outcome data by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. These findings, the researchers say, argue for expanding newborn...

2014-07-30 23:00:27

Dr. Brett Bolton, founder and medical director at Great Hair Transplants, has now surpassed 400 hair transplant patient recommendations. The new interactive product and service review website, Trusted Societies, has Dr Bolton listed as the top hair transplant surgeon with 420 MAXHARVEST™ patient reviews. Brentwood, TN. (PRWEB) July 31, 2014 The hair transplant society is just one of the hundreds of "Trusted Societies" listed on the new interactive business review website....

2014-07-30 12:30:36

Findings presented at the 2014 World Transplant Congress SAN FRANCISCO, July 30, 2014 /PRNewswire/ -- A study presented at the 2014 World Transplant Congress evaluated the safety and efficacy of CSL Behring's C1 Inhibitor (C1-INH) concentrate in preventing antibody-mediated rejection following kidney transplants in highly sensitized patients. C1-INH is a human protein and an important inhibitor of the complement system. http://photos.prnewswire.com/prnvar/20100914/PH63692LOGO The...

2014-07-28 13:28:02

University of Oxford Oxford University scientists have shown that a powerful drug given at the time of a kidney transplant operation not only halves the early risk of rejection, but that it also allows a less toxic regimen of anti-rejection drugs to be used after the operation. The key results are reported in The Lancet and presented at the World Transplant Congress in San Francisco today. They will help doctors faced with a difficult transplant conundrum: the powerful combinations of...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related